ADA Scientific Sessions 2026 Abstract·6 JunBody Composition and Functional Outcomes of HM17321, a CRFR2-Selective UCN2 Analog, Alone and in Combination with Myostatin/Activin Inhibition in DIO MiceExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunProtective Effects of HM17321, a Novel UCN2 Analog, on Obesity-Associated Musculoskeletal Diseases in Mouse ModelsExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunHM17321, a CRFR2 Selective UCN2 Analog, Prevents Muscle Loss and Functional Decline in Sarcopenic MiceExperiments in miceSarcopeniaPaper
ADA Scientific Sessions 2025 Abstract·13 JunA Novel UCN2 Analog HM17321 with HM15275 Improves Body Composition in Mouse Model of ObesityExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunA Novel CRFR2 Selective UCN2 Analog, HM17321, Facilitates Weight Loss and Improves Body Composition across Animal Models of ObesityExperiments in animalsInterventionsPaper